121 related articles for article (PubMed ID: 32157528)
1. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Zhang GC; Sun JL; Zhu HR; Shi X; Song GQ; Weng SQ; Dong L; Liu TT; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1546-1557. PubMed ID: 32157528
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth
Hwang Y; Kim LC; Song W; Edwards DN; Cook RS; Chen J
Cancer Res; 2019 Jul; 79(13):3178-3184. PubMed ID: 31085701
[TBL] [Abstract][Full Text] [Related]
3. Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
Yu XN; Guo HY; Liu TT; Zhang GC; Zhu HR; Shi X; Song GQ; Jiang XM; Huang XX; Weng SQ; Dong L; Shen XZ; Huang YQ; Zhu JM
J Cell Biochem; 2020 Apr; 121(4):2938-2949. PubMed ID: 31692072
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
8. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
9. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.
Zhang E; Chen S; Tang H; Fei C; Yuan Z; Mu X; Qin Y; Liu H; Fan Y; Tan M; Wang X
Cancer Sci; 2022 Jan; 113(1):91-108. PubMed ID: 34741373
[TBL] [Abstract][Full Text] [Related]
10. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of autophagy-related gene 5 indicates poor prognosis in patients with hepatocellular carcinoma.
Guo HY; Yu XN; Zhang GC; Yin J; Dong L; Liu TT; Qian ZP; Zhu JM; Shen XZ
J Dig Dis; 2023; 24(6-7):399-407. PubMed ID: 37596850
[TBL] [Abstract][Full Text] [Related]
12. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
13. mLST8 Promotes mTOR-Mediated Tumor Progression.
Kakumoto K; Ikeda J; Okada M; Morii E; Oneyama C
PLoS One; 2015; 10(4):e0119015. PubMed ID: 25906254
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.
Bai B; Lin Y; Hu J; Wang H; Li L; Zhao S; Zhang J; Meng W; Yue P; Bai Z; Li X
Oncol Rep; 2019 Mar; 41(3):1539-1548. PubMed ID: 30747220
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
17. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
18. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Gao J; Jia WD
Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
[TBL] [Abstract][Full Text] [Related]
19. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
20. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
